Stilnox CR 6.25 mg
Stilnox CR 6.25 mg is a medicine authorised by Swissmedic under authorisation number 57409. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 December 2005 and the authorisation is valid without a time limit. ATC code N05CF02 places the medicine in the group Psycholeptics.
| Authorisation number | 57409 |
|---|---|
| Name | Stilnox CR 6.25 mg |
| Full name | Stilnox CR 6.25 mg, comprimés à libération contrôlée |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05CF02 |
| First authorisation | 16 December 2005 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Stilnox CR 6.25 mg, comprimés à libération contrôlée | B | 16 December 2005 |
| 2 | Stilnox CR 12.5 mg, comprimés à libération contrôlée | B | 16 December 2005 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 7 | Tablette(n) | N05CF02 | 01.03.1. | B |
| 4 | 14 | Tablette(n) | N05CF02 | 01.03.1. | B |
| 6 | 28 | Tablette(n) | N05CF02 | 01.03.1. | B |
| 8 | 7 | Tablette(n) | N05CF02 | 01.03.1. | B |
| 10 | 14 | Tablette(n) | N05CF02 | 01.03.1. | B |
| 12 | 28 | Tablette(n) | N05CF02 | 01.03.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Stilnox CR 6.25 mg authorised in Switzerland?
Yes. Stilnox CR 6.25 mg is authorised by Swissmedic under authorisation number 57409, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Stilnox CR 6.25 mg have?
Stilnox CR 6.25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Stilnox CR 6.25 mg?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.